Method for protecting a mammalian host against infection by Brucella

dc.contributor.assigneeBoard of Supervisors of Louisiana State University and Agricultural anden
dc.contributor.assigneeVirginia Polytechnic Institute and State Universityen
dc.contributor.assigneeThe Board of Regents for Oklahoma State Universityen
dc.contributor.assigneeCornell Research Foundation, Inc.en
dc.contributor.inventorEnright, Frederick M.en
dc.contributor.inventorSchurig, Gerhardt G.en
dc.contributor.inventorWinter, Alexander J.en
dc.contributor.inventorWyckoff, III, John H.en
dc.date.accessed2016-08-19en
dc.date.accessioned2016-08-24T17:54:14Zen
dc.date.available2016-08-24T17:54:14Zen
dc.date.filed1997-12-11en
dc.date.issued2001-07-24en
dc.description.abstractVaccines against facultative intracellular pathogens are disclosed. A host is vaccinated with non-viable but metabolically active agents. The non-viable agents produce immunogenic components that elicit protective host immune responses, with minimal likelihood of host infection by the vaccine agent. Living agents, either attenuated or virulent, are exposed to a dose of gamma irradiation (or other strong mutagen) that is sufficient to limit or prevent the replication of the agents within the host, but that is insufficient to stop the metabolic activities of the agent. In vitro exposure of a microbial agent to the damaging effects of gamma irradiation or of another strong mutagen induces certain stress responses in the infectious agent. These stress responses are similar to the stress responses that the virulent agent would produce within the tissues of the host. The stress responses include the production of antigens that stimulate appropriate host immune responses when the irradiated agent is used in a vaccine. Examples of facultative intracellular pathogens for which non-viable vaccine agents may be made in accordance with the present invention include various bacterial pathogens (e.g., Brucella sp., Brucella abortus, Mycobacterium sp., Mycobacteriun lepraemurum, Mycobacterium tuberculosis, Salmonella sp., Salmonella typhimurium); various mycotic pathogens (e.g., Blastomyces, Histoplasma, Cocidioides); and various protozoal pathogens (e.g., Leishmania, Trypanosomas).en
dc.format.mimetypeapplication/pdfen
dc.identifier.applicationnumber8989089en
dc.identifier.patentnumber6264952en
dc.identifier.urihttp://hdl.handle.net/10919/72433en
dc.identifier.urlhttp://pimg-fpiw.uspto.gov/fdd/52/649/062/0.pdfen
dc.language.isoen_USen
dc.publisherUnited States Patent and Trademark Officeen
dc.subject.cpcA61K39/098en
dc.subject.cpcY10S424/823en
dc.subject.cpcY10S424/824en
dc.subject.cpcY10S435/822en
dc.subject.uspc424/184.1en
dc.subject.uspcother424/93.1en
dc.subject.uspcother424/93.4en
dc.subject.uspcother424/234.1en
dc.subject.uspcother424/823en
dc.subject.uspcother424/824en
dc.subject.uspcother435/243en
dc.subject.uspcother435/822en
dc.titleMethod for protecting a mammalian host against infection by Brucellaen
dc.typePatenten
dc.type.dcmitypeTexten
dc.type.patenttypeutilityen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
6264952.pdf
Size:
777.13 KB
Format:
Adobe Portable Document Format